IP Frequently – where, while always fair, nothing is off limits. We invite you to join the conversation.
Check in with Brad Sheafe, Chief Intellectual Property Officer (CIPO) and David Pridham, CEO of Dominion Harbor, respectively as they weigh in on the latest IP protection strategy in assigning one’s patent rights to legally protected sovereign entities in a last ditch effort to protect one’s patent rights from the Patent Trial and Appeals Board (PTAB).
Specifically, they are directing their attention to the recent Allergan case where they have agreed to pay the St. Regis Mohawk upwards of $15M a year to maintain ownership of their Restasis drug patents in an effort to exclude their scrutiny of both the Federal court system and the PTAB simultaneously.
Panel stacking – assigning specific Judges to specific cases in an effort predict or affect a particular outcome. Worse, the USPTO has gone on congressional record admitting to as much with not a hint of remorse or collusion guilt.
PTAB – is not an Article III tribunal however it acts as one on ruling over private property issues e.g. Patents